Partners Exhibitors Sponsors

SPONSORS

1.

Fluidigm sponsor exhibitor FLUIDIGM

Fluidigm is committed to empowering the cancer immunotherapy community with research tools to interrogate the tumor microenvironment with unprecedented resolution. Whether you seek to target new biomarkers or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you reach your next research breakthrough.

View more on www.fluidigm.com

2.

NanoString Technologies

NanoString is a life sciences company focused on cancer research and diagnostics. Proven in over 2,000 peer-reviewed publications, the nCounter® System can combine with 3D biology™ technology to create novel biomarkers. The Prosigna® Breast Cancer Prognostic Gene Signature Assay provides FDA 510(k)-cleared diagnostics with the nCounter Dx Analysis System.

View more on nanostring.com

EXHIBITORS

1.

10x Genomics

10x Genomics, Inc. is building tools for scientific discovery that reveal and address the true complexities of biology and disease. Through a combination of novel microfluidics, chemistry and bioinformatics, our award-winning Chromium System is enabling researchers around the world to more fully understand the fundamentals of biology at unprecedented resolution and scale.

#GOEXPONENTIAL

View more on www.10xGenomics.com

2.

AID Logo - transparent 1000x600 AID GmbH

AID GmbH is a German family-owned life science and diagnostics company, founded in 1989. AID GmbH develops, manufactures, and globally markets automated Reader Systems and a wide range of IVD/CE marked assays for EliSpot/FluoroSpot, molecular diagnostics and serology. The versatile AID Reader Systems cope with colorimetric and fluorometric assays in 6-, 12-, 24-, 48-, 96-, and 384-well plate formats. AID GmbH products are ISO 13485 certified and CE marked.

View more on https://www.aid-diagnostika.com/en/

3.

CeGaT

CeGaT is a leading global provider of genetic diagnostics and mutation-related disease analyses. The company combines its next-generation sequencing process and analysis pipelines with its medical expertise to support physicians and oncologists in choosing the optimal therapeutic strategy. CeGaT’s tumor diagnostics portfolio provides a detailed analysis of causative mutations and determines TMB and MSI for therapeutic decisions on immunotherapies.

View more on https://www.cegat.de/en/

4.

 Fluidigm sponsor exhibitor FLUIDIGM

Fluidigm is committed to empowering the cancer immunotherapy community with research tools to interrogate the tumor microenvironment with unprecedented resolution. Whether you seek to target new biomarkers or to optimize the effectiveness of checkpoint inhibitors, CAR T cells or cancer vaccines, Fluidigm can help you reach your next research breakthrough.

View more on www.fluidigm.com

5.

Indica Labs

Indica Labs’ image analysis and collaborative image management software platforms, HALO, HALO-AI and HALO -Link, facilitate quantitative evaluation of digital pathology images.  With unmatched ease-of-use, speed and scalability, pharmaceutical, healthcare and research organizations worldwide are using Indica Labs’ software and services for high-throughput, quantitative tissue analysis in oncology, neuroscience, metabolism, and toxicology.

View more on www.indicalab.com

6.

NanoString Technologies

NanoString is a life sciences company focused on cancer research and diagnostics. Proven in over 2,000 peer-reviewed publications, the nCounter® System can combine with 3D biology™ technology to create novel biomarkers. The Prosigna® Breast Cancer Prognostic Gene Signature Assay provides FDA 510(k)-cleared diagnostics with the nCounter Dx Analysis System.

View more on nanostring.com

7.

Society for Immunotherapy of Cancer (SITC)

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Established in 1984, SITC serves scientists, clinicians, patients, patient advocates, government representatives and industry leaders from around the world. Currently, SITC has more than 2,400 members who represent 22 medical specialties in 42 countries around the world.

View more on sitcancer.org

PARTNERS

1.

Cahon Logo

Chinese American Hematologist and Oncologist Network (CAHON)

http://www.cahon.org/

2.

SITC-log-hires Society for Immunotherapy of Cancer (SITC)

http://www.sitcancer.org/home

MEDIA PARTNERS

1.

Accelerating Cancer Immunotherapy Research

ACIR’s mission is to fast-track Cancer Immunotherapy research by providing researchers with a weekly synopsis of the key advances in this field, free-of-charge. Our scientists scour PubMed and curate the key publications we believe researchers should be aware of. We hope that by making it easier for all researchers to stay up-to-date, our summary will enhance the work of many, bringing us closer to a cure.

https://acir.org/

2.

18th European Congress of Internal Medicine

http://www.efim.org/ecim2019/

3.

The International Symposium on Immunotherapy

The Institute for Cancer Vaccines and Immunotherapy (ICVI) are pleased to announce that the 4th International Symposium on Immunotherapy will be held at the prestigious Royal Society in London, on 24th and 25th May 2019.  The first three symposia were a huge success, and once again we have attracted world leading experts to talk about this important and growing field of cancer treatment.  Headed up by the head of our organisation, Professor Angus Dalgleish, our confirmed speakers include Irving Weisssman, Carl June on CAR T cells, Paul Sondel, Riccardo Ferro, Raj Chopra, Roger Pertwee on Cannabinoids and cancer and many more.

We are accepting abstracts. Registration is now open.

www.icvis.org.uk

4.

JSCIMED Central logo JSM Clinical Oncology and Research

https://jscimedcentral.com/

SPONSORSHIP AND EXHIBITION MATTERS

Exhibition Management & Congress Consultancy bv  ROSE-logo-with-text-Rose-International without white backrgound
Contact Flora van Laer
E-Mail fvanlaer@rose-international.com
Telephone +31 70 383 8901